News

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
The U.S. federal government's "covid.gov" website now redirects to a White House page offering up the unproven theory that ...
As the prospect of sector-specific tariffs under the second Trump administration continues to rattle drugmakers, a more ...
US flu activity declined steadily again last week, with rates of influenza-like illness (ILI) dropping further and staying ...
US hospital data from 2018 through 2022 shows carbapenem-resistant Acinetobacter baumanii accounted for more than one third of all Acinetobacter nfections.
Leerink Partners analyst Puneet Souda maintained a Buy rating on Bio-Techne (TECH – Research Report) yesterday and set a price target of ...